"made in Chengdu" vaccine against XBB and other novel coronavirus was approved for emergency use.

Xinhua News Agency, June 8 / PRNewswire-FirstCall-Asianet /-- according to the West China Hospital of Sichuan University, with the approval of relevant state departments, the recombinant trivalent novel coronavirus (XBB+BA.5+Delta variant) trimer protein vaccine (Sf9 cell) developed by Sichuan Dahuaxi / Wesker Biology (Sf9 cell)-- Weikexin ®3-valent XBB vaccine was brought into emergency use. This is the world's first approved emergency use of COVID-19 vaccine against mutants such as XBB. It is expected that the public will be able to receive the vaccine in the next 1-2 months.